PCM
CSBR icon

PAR Capital Management’s Champions Oncology CSBR Stock Holding History

PAR Capital Management’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-384,282
Closed -$646K – 77
2016
Q3 		$646K Sell
384,282
-412,618
-52% -$768K 0.01% 84
2016
Q2 		$1.71M Sell
796,900
-36,433
-4% -$114K 0.03% 75
2016
Q1 		$3.03M Hold
833,333
– – 0.05% 72
2015
Q4 		$2.98M Hold
833,333
– – 0.05% 74
2015
Q3 		$4.46M Buy
+833,333
New +$5.44M 0.09% 66

Other funds holding CSBR

BPI
Battery Partners IX Boston, Massachusetts $22.4M AUM 27.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
SSB
Sandy Spring Bank Olney, Maryland $2.38B AUM 8.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PAR Capital Management's CSBR Position: Q4 2016 in Review

PAR Capital Management sold out of Champions Oncology (CSBR) in Q4 2016, closing a stake of 384,282 shares — an estimated $646K sold.

PAR Capital Management first reported a position in CSBR in Q3 2015 and held it in 5 quarters. The position peaked at $4.46M in Q3 2015. 11 funds tracked by Wall St. Rank hold CSBR as of Q4 2016.

  • PAR Capital Management reported no remaining Champions Oncology position as of Q4 2016 after selling out during the quarter.
  • PAR Capital Management sold 384,282 Champions Oncology shares in Q4 2016, an estimated $646K.
  • PAR Capital Management first reported a position in Champions Oncology in Q3 2015 and held it in 5 quarters.
  • PAR Capital Management's Champions Oncology position peaked at $4.46M in Q3 2015.
  • 11 funds tracked by Wall St. Rank held Champions Oncology as of Q4 2016.

Based on PAR Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.